Unleashing Our Potential— Pharmacists' Role in Vaccination and Public Health

2020 ◽  
Vol 35 (9) ◽  
pp. 372-378
Author(s):  
Arjun Poudel ◽  
Esther T. L. Lau ◽  
Chris Campbell ◽  
Lisa M. Nissen

One of the greatest innovations in health care has been the development of vaccines and immunization programs that have significantly minimized the morbidity and mortality resulting from vaccine preventable diseases. While vaccines were traditionally used against infectious diseases, recent advances in technology have led to the development of vaccines for noncommunicable diseases and chronic conditions. Vaccinations are considered the most cost-effective intervention in public health that has the potential to save millions of lives every year. Despite the availability and effectiveness of vaccines for many diseases, immunization programs, and service uptake remain underused in many countries. This is mainly because of the lack of easy access to vaccinations, risk-benefit perceptions, false beliefs, and concerns about the side effects. Vaccine hesitancy—the reluctance or refusal to vaccinate, is listed as one of the top 10 threats to global health.

2020 ◽  
Vol 35 (9) ◽  
pp. 372-378
Author(s):  
Arjun Poudel ◽  
Esther T. L. Lau ◽  
Chris Campbell ◽  
Lisa M. Nissen

One of the greatest innovations in health care has been the development of vaccines and immunization programs that have significantly minimized the morbidity and mortality resulting from vaccine preventable diseases. While vaccines were traditionally used against infectious diseases, recent advances in technology have led to the development of vaccines for noncommunicable diseases and chronic conditions. Vaccinations are considered the most cost-effective intervention in public health that has the potential to save millions of lives every year. Despite the availability and effectiveness of vaccines for many diseases, immunization programs, and service uptake remain underused in many countries. This is mainly because of the lack of easy access to vaccinations, risk-benefit perceptions, false beliefs, and concerns about the side effects. Vaccine hesitancy—the reluctance or refusal to vaccinate, is listed as one of the top 10 threats to global health.


2020 ◽  
Vol 30 (Supplement_5) ◽  
Author(s):  
◽  

Abstract The world is facing multiple health challenges, among those the outbreaks of vaccine-preventable diseases and the rise of anti-vaccination groups. Vaccination is one of the most cost-effective ways of avoiding disease; it currently prevents 2-3 million deaths a year and a further 1.5 million could be avoided if global coverage is improved. Moreover, global immunization will contribute towards achieving broader global health goals under the UHC and SDG initiatives. Barriers to immunization may vary according to the country and specific context ranging from hesitancy, inappropriate communication, lack of resources, access, individual belief, management of adverse events following immunization etc. Vaccine hesitancy threatens to reverse progress made in tackling vaccine-preventable diseases and is listed by WHO in the 10 threats to global health in 2019. Access to vaccinations is sometimes difficult especially in rural areas affecting most vulnerable populations. Immunization history is not always well managed thus affecting the proper vaccination for all ages. Immunization is one of the best uses of limited public funds for health; however, financing for immunizations are often not covering in a sustainable matter the needs. The World Federation of Public Health Associations has developed a high-level “International Immunization Policy Taskforce” on vaccination policies to engage with public health associations, international organizations and like-minded partners to sustain the development, adoption and implementations of key vaccination policies at country level. The taskforce has developed a position paper that will be launched during the workshop to debate about role and responsibilities as well effective approaches to be applied both in developed and developing. The position paper has its roots in vaccination as human right and as a key component of UHC and SGD initiatives. Global immunization is crucial for every individual and the broader community to prevent diseases, promote health and wellbeing and protect the global population as highlighted in WFPHA Global Charter for the Public's Health. Key experts from different parts of the world will discuss strategies and synergies to create a global coordinated advocacy movement to foster engagement for equitable and effective global immunisation by governments and society at large. Key messages Vaccination challenges may vary from developed & developing countries. Responsibility for immunization uptake lies at different levels. Analyses, advocacy, action are key to prevent & face epidemics. Vaccination is not a personal choice rather a political choice. A strong advocacy movement by PHW is key to guarantee the best equitable and sustainable immunization worldwide.


Author(s):  
Gopalakrishnan S. ◽  
Sujitha P.

Immunization is the most cost-effective scientific method of reducing childhood morbidity and mortality. In India the national immunization programme has not been able to attain complete coverage of the eligible children and hence mortality due to vaccine preventable diseases is approximately 5 lakhs annually.  Every year, 89 lakhs children are at risk to develop vaccine preventable diseases due to lack of immunization. While most people vaccinate according to the recommended schedule, this success is challenged by individuals and groups who delay, hesitant or refuse vaccines due to various reasons. Despite the realization of compulsory scheduling of vaccines, there are an alarming number of parents who do not permit the vaccination of their children as scheduled. Vaccine hesitancy refers to a delay in acceptance or refusal of vaccines despite the availability of vaccination services. WHO in 2019 listed vaccine hesitancy as one of the ten global health threats. The recent vaccination coverage evaluation studies have shown that there is a perceptible drop in the vaccine coverage in most parts of India and also that the disparity in the urban-rural coverage is also widening. Hence an evaluation of the reasons for vaccine hesitancy is vital at present to strengthen the universal immunization program. The authors are trying to trace the present status and reasons for vaccine hesitancy reported in recent times, which can lead to outbreaks of already controlled vaccine preventable diseases and to identify strategies which are being implemented to overcome the vaccine hesitancy.


2019 ◽  
Vol 2 (1) ◽  
pp. 77-78
Author(s):  
Niresh Thapa ◽  
Muna Maharjan

Diabetes is an important public health concern which is increasing rapidly in developing countries. It is challenging to prevent and manage diabetes in a rural setting. The Integrated Diabetic Clinic is comprehensive diabetes care under one roof. Its aim is to provide efficient accessible and affordable comprehensive care. It will make a huge difference in the management of diabetes. This clinic will play a major role in unifying different aspects of health care under one roof and offer the most comprehensive and cost-effective accessible health care to minimize mortality and morbidity associated with diabetes.


2021 ◽  
Author(s):  
Kazi Asequl Arefin ◽  
Anwar Hossain ◽  
Md. H Asibur Rahman

Abstract This study aims to look at the causes of COVID-19 vaccine hesitancy in Bangladesh by examining the cultural and religious values, lack of trust, misinformation, and fear of side effects as predictors of vaccine hesitancy. Self-developed measurement items, developed based on the expert's opinion, were used to accomplish the objective. Data was gathered from 268 respondents who represented their community through both an online and a physical survey. SPSS version 25 was used to optimize descriptive statistics. Besides, SmartPLS 3.0 was used to examine the hypotheses using the PLS-SEM approach. The study confirms that lack of trust, misinformation and fear of side effects all play a role in vaccine hesitancy. Besides, the results have many significant implications for public health policymakers, vaccine manufacturers and distributors, and the media. Besides that, the study proposes some new research avenues for overcoming this study's limitations and gaining more detailed information on the topic.


Author(s):  
Raj S. Bhopal

Achieving internationally agreed prevention strategies is extremely difficult and doing so for South Asians, specifically, is tougher still. Most guidance is centred on individual level behaviour change. The challenge is to produce focused, low cost, effective actions, underpinned by clear, simple, and accurate explanations of the causes of the phenomenon. The key messages are that the high risk of CVD and DM2 in urbanizing South Asians is not inevitable. It is not innate or genetic. Similarly, the risks are unlikely to be acquired in utero, birth, or infancy, and programmed in a fixed way. Rather, exposure to risk factors in childhood, adolescence, and most particularly in adulthood is the key. In addition to the established causes we need to research additional factors especially those identified as novel in Chapter 9. National legislation and policy that alters environments to reduce exposure to risk factors and increase exposure to protective factors is essential.


2008 ◽  
Vol 9 (2) ◽  
pp. 67-103 ◽  
Author(s):  
Timothy B. Baker ◽  
Richard M. McFall ◽  
Varda Shoham

The escalating costs of health care and other recent trends have made health care decisions of great societal import, with decision-making responsibility often being transferred from practitioners to health economists, health plans, and insurers. Health care decision making increasingly is guided by evidence that a treatment is efficacious, effective–disseminable, cost-effective, and scientifically plausible. Under these conditions of heightened cost concerns and institutional–economic decision making, psychologists are losing the opportunity to play a leadership role in mental and behavioral health care: Other types of practitioners are providing an increasing proportion of delivered treatment, and the use of psychiatric medication has increased dramatically relative to the provision of psychological interventions. Research has shown that numerous psychological interventions are efficacious, effective, and cost-effective. However, these interventions are used infrequently with patients who would benefit from them, in part because clinical psychologists have not made a convincing case for the use of these interventions (e.g., by supplying the data that decision makers need to support implementation of such interventions) and because clinical psychologists do not themselves use these interventions even when given the opportunity to do so. Clinical psychologists' failure to achieve a more significant impact on clinical and public health may be traced to their deep ambivalence about the role of science and their lack of adequate science training, which leads them to value personal clinical experience over research evidence, use assessment practices that have dubious psychometric support, and not use the interventions for which there is the strongest evidence of efficacy. Clinical psychology resembles medicine at a point in its history when practitioners were operating in a largely prescientific manner. Prior to the scientific reform of medicine in the early 1900s, physicians typically shared the attitudes of many of today's clinical psychologists, such as valuing personal experience over scientific research. Medicine was reformed, in large part, by a principled effort by the American Medical Association to increase the science base of medical school education. Substantial evidence shows that many clinical psychology doctoral training programs, especially PsyD and for-profit programs, do not uphold high standards for graduate admission, have high student–faculty ratios, deemphasize science in their training, and produce students who fail to apply or generate scientific knowledge. A promising strategy for improving the quality and clinical and public health impact of clinical psychology is through a new accreditation system that demands high-quality science training as a central feature of doctoral training in clinical psychology. Just as strengthening training standards in medicine markedly enhanced the quality of health care, improved training standards in clinical psychology will enhance health and mental health care. Such a system will (a) allow the public and employers to identify scientifically trained psychologists; (b) stigmatize ascientific training programs and practitioners; (c) produce aspirational effects, thereby enhancing training quality generally; and (d) help accredited programs improve their training in the application and generation of science. These effects should enhance the generation, application, and dissemination of experimentally supported interventions, thereby improving clinical and public health. Experimentally based treatments not only are highly effective but also are cost-effective relative to other interventions; therefore, they could help control spiraling health care costs. The new Psychological Clinical Science Accreditation System (PCSAS) is intended to accredit clinical psychology training programs that offer high-quality science-centered education and training, producing graduates who are successful in generating and applying scientific knowledge. Psychologists, universities, and other stakeholders should vigorously support this new accreditation system as the surest route to a scientifically principled clinical psychology that can powerfully benefit clinical and public health.


2021 ◽  
Vol 9 (3) ◽  
pp. 213-226
Author(s):  
Amos Kijjambu

Vaccine hesitancy to immunization against the childhood vaccine-preventable diseases is increasingly becoming a concern worldwide, which negatively impacts the parents’ willingness to vaccinate their children. The objective of this study was to establish the current prevalence of vaccine hesitancy and the factors that determine parent’s hesitancy to childhood immunizations in Nansana Municipality, Wakiso District, Uganda. This was a cross-sectional mixed methods study, utilizing both qualitative and quantitative approaches. Evaluation of the determinants of vaccine hesitancy was carried out on 344 parents of children under 24 months, using simple random sampling on pre-tested structured questionnaires. Data was analyzed using SPSS 20.0 software. Additionally, 2 focus group discussions with parents were also conducted. Vaccine hesitancy was found to be 27.6%. Education level (AOR=4.9, 95% CI, 2.6 -29.5, p=0.01), belief in vaccine effectiveness (AOR= 0.47, 95% CI, 0.17 – 0.97, p=0.01), health workers attitude (AOR=0.22, 95% CI, 0.06 - 0.86, p=0.03), timing of immunization service clinic (AOR = 3.4, 95% CI, 1.8 – 6.4, p=0.01) and adequate information provision (AOR = 0.64, 95% CI, 0.16 – 0.99, p=0.04), were the factors that were independently determining vaccine hesitancy. The vaccine hesitancy prevalence rate is comparatively similar to previous urban area studies. Despite parents overwhelmingly believing in vaccines protecting their children from vaccine-preventable disease, these same parents, express concerns regarding timing of the clinic and the side effects of vaccines. There is a need to improve on communication and information flow to address the many vaccine safety concerns, such as side effects. Keywords: Childhood, Determinants, Hesitancy, Immunization, Urban.


Author(s):  
Hannah Jose ◽  
Vineet Kumar Pathak

The struggle against COVID-19, which once started as an amicable endeavor with an anticipated climax has now turned into an unending, mysterious puzzle with lesser hope. What impacts more is the deficiency of financial backups in the health sector, for such an unexpectedly long duration. All these are pointing us towards a more sustainable, cost-effective method to fight against COVID-19, where the daily health and lifestyle of people are also considered. Maintenance of provision of essential health care services is important and urgent since this is the only way to decrease the indirect morbidity and mortality from other health conditions, thereby preventing the health system from collapse. Various new reforms have been made in health policies of different vulnerable groups including, people living with chronic diseases, the elderly, children and mothers, and pregnant women. To avoid the re-emergence of vaccine-preventable diseases and also future similar contagious diseases, reforms are also made in immunization services. Implementation of these amendments in the health care sector is a need of the hour and it demands a broader perspective with a long-term goal. Further, identifying gaps for innovative initiatives in the same direction are also to be welcomed, for a sustainable post-COVID-19 phase.


2020 ◽  
Vol 30 (Supplement_5) ◽  
Author(s):  
L Martins ◽  
N Cunha ◽  
C Baebieri ◽  
Y Pamplona ◽  
N Loureiro ◽  
...  

Abstract Introduction Immunization is a human right, being considered an action of the most successful and cost-effective in public health. In Brazil, it is an action that is linked to primary health care, In Brazil, the National Immunization Program (PNI), created in 1973, is recognized as a world reference of public health policy, as it offers all vaccines recommended by the World Organization health care in its national vaccination calendar. Objective Spatial analysis of vaccination coverage of children aged 0 to 11 months in Paraíba in 2016. Methods Cross-sectional study, with information on doses applied to children under 1 year of age obtained at the PNI, by municipality of Paraíba. Live birth data from the Live Birth information system (SINASC). Descriptive analysis, chi-square test, spatial analysis. Results In Paraíba, 54.3% of the municipalities had adequate vaccination coverage, for BCG we have 68%, Hepatitis B (34.5%), Hib and DTP (35%), Polio (29.6%), pneumococcal (46.6%) and meningococcal (42.6%). The sertão paraibano is the mesoregion with the largest number of municipalities in the state with adequate vaccination coverage (p < 0.01), the paraiba forest is the region with the highest number of municipalities with very low coverage (p < 0.01). Conclusions Thus, Paraíba does not present a homogeneous vaccination coverage, not having 'herd immunity'. This fact leaves the state vulnerable to the return of immunopreventable diseases and thus at risk of raising infant morbidity and mortality, constituting an important public health problem. Key messages Immunization is a human right, being considered an action of the most successful and cost-effective in public health. Paraíba does not present a homogeneous vaccination coverage, not having 'herd immunity'.


Sign in / Sign up

Export Citation Format

Share Document